ABSTRAL

This brand name is authorized in United States. It is also authorized in Australia, Cyprus, Finland, France, Ireland, Israel, Japan, Netherlands, Singapore, Spain, Turkey, UK.

Active ingredients

The drug ABSTRAL contains one active pharmaceutical ingredient (API):

1	Fentanyl UNII MUN5LYG46H - FENTANYL CITRATE
	Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects.
	Read more about Fentanyl

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ABSTRAL Sublingual tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02AB03	Fentanyl	N Nervous system → N02 Analgesics → N02A Opioids → N02AB Phenylpiperidine derivatives
Discover more medicines within N02AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10600X, 10601Y, 10602B, 10603C, 10604D, 10606F, 10607G, 10608H, 10610K, 10611L, 10612M, 10613N
ES	Centro de información online de medicamentos de la AEMPS	70501, 70502, 70504, 70507, 70508, 70511
FI	Lääkealan turvallisuus- ja kehittämiskeskus	029211, 029222, 029255, 029277, 029300, 029311, 029335, 029357
FR	Base de données publique des médicaments	60282999, 61464150, 61578296, 63451714, 67144513, 68336954
GB	Medicines & Healthcare Products Regulatory Agency	149484, 149485, 149488, 149491, 149495, 149496, 149500, 149501, 149505, 149506
IE	Health Products Regulatory Authority	10880, 10881, 10882, 10883, 10884, 10885, 10886, 10887, 10888, 10889, 10890, 10891
IL	מִשְׂרַד הַבְּרִיאוּת	7242, 7243, 7244, 7245, 7610
JP	医薬品医療機器総合機構	8219001F1020, 8219001F2026, 8219001F3022
NL	Z-Index G-Standaard, PRK	98175, 98183, 98191, 98205, 98213, 98221
SG	Health Sciences Authority	15147P, 15148P, 15149P, 15150P, 15151P, 15152P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699538055600, 8699538055617, 8699538055624, 8699538055631
US	FDA, National Drug Code	42358-100, 42358-200